ATP6V1C1 and breast carcinoma: Based on this, we subjected the ATP6V1C1 inhibitor to breast cancer cells and we confirmed that inhibition of autophagy/lysosome by VAM sensitized cancer cells to chemotherapy through blockage of protective autophagy.